Pharmaceutical
Ren Bioscience is an early stage biotechnology company developing therapeutics for rare autoimmune, retinal and neurodegenerative diseases. The most advanced program leverages a novel target to deliver a transformative neurodegenerative therapy. The therapy targets a reduction in demyelination and pain signaling.